Astera Labs, Inc. $ALAB Stock: Wealth Management Partners LLC Cuts Holdings

Wealth Management Partners LLC trimmed its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 8.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,627 shares of the company’s stock after selling 2,169 shares during the quarter. Astera Labs accounts for about 1.9% of Wealth Management Partners LLC’s portfolio, making the stock its 13th largest position. Wealth Management Partners LLC’s holdings in Astera Labs were worth $8,411,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Crossmark Global Holdings Inc. raised its stake in shares of Astera Labs by 19.0% during the third quarter. Crossmark Global Holdings Inc. now owns 1,994 shares of the company’s stock valued at $710,000 after acquiring an additional 318 shares during the last quarter. Capstone Capital Management Ltd bought a new stake in Astera Labs during the third quarter valued at $944,000. Nisa Investment Advisors LLC grew its stake in Astera Labs by 11.8% during the third quarter. Nisa Investment Advisors LLC now owns 9,327 shares of the company’s stock worth $3,320,000 after purchasing an additional 983 shares during the period. Integrated Advisors Network LLC grew its position in shares of Astera Labs by 4.8% during the 3rd quarter. Integrated Advisors Network LLC now owns 983 shares of the company’s stock worth $350,000 after buying an additional 45 shares during the period. Finally, Robeco Institutional Asset Management B.V. grew its holdings in Astera Labs by 5.3% in the third quarter. Robeco Institutional Asset Management B.V. now owns 151,807 shares of the company’s stock worth $54,039,000 after purchasing an additional 7,644 shares during the period. 60.47% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of analysts have commented on the stock. Roth Capital restated a “buy” rating and set a $450.00 price target on shares of Astera Labs in a research note on Wednesday, August 5th. Susquehanna increased their price target on Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research report on Friday, July 31st. Jefferies Financial Group lifted their target price on Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th. Royal Bank Of Canada upped their price objective on Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a research note on Wednesday, August 5th. Finally, Weiss Ratings upgraded Astera Labs from a “hold (c)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. Eleven analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $344.17.

Insider Buying and Selling

In related news, General Counsel Philip Mazzara sold 6,801 shares of Astera Labs stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.50, for a total value of $2,315,740.50. Following the completion of the transaction, the general counsel directly owned 96,542 shares in the company, valued at approximately $32,872,551. The trade was a 6.58% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction that occurred on Wednesday, September 2nd. The shares were sold at an average price of $274.96, for a total transaction of $2,472,990.24. Following the completion of the transaction, the director owned 3,309 shares of the company’s stock, valued at $909,842.64. This represents a 73.10% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 408,558 shares of company stock worth $127,306,034 in the last 90 days. 10.40% of the stock is currently owned by company insiders.

Astera Labs Stock Up 1.8%

Shares of NASDAQ:ALAB opened at $290.06 on Thursday. The firm has a market capitalization of $50.32 billion, a PE ratio of 183.74 and a beta of 3.68. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48. The company has a 50-day moving average price of $313.13 and a two-hundred day moving average price of $302.11.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. During the same quarter last year, the company earned $0.44 earnings per share. The company’s revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Analysts anticipate that Astera Labs, Inc. will post 2.70 earnings per share for the current fiscal year.

About Astera Labs

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.